Drug intelligence / Profile preview

arsenite

Development stage
Unknown
Lead developer
Teva Pharmaceutical
Modality
Small Molecules
Administration
Oral, Inhalation, Rarely Intravenous (historical/obsolete Use)
01

Overview

Arsenite refers to the class of inorganic compounds containing **arsenic in the +3 oxidation state**, classically represented as arsenic oxyanions such as AsO₂⁻ or AsO₃³⁻[9]. These compounds are highly **toxic** and occur naturally, as well as synthetically, and are encountered in both environmental contamination (e.g., groundwater) and occupational settings[8][4]. Arsenite ions disrupt biological processes by binding with sulfhydryl groups on cysteine residues of proteins and enzymes, inhibiting their activity—particularly in energy metabolism and cellular signaling[2][4]. This mechanism underlies the toxicity and carcinogenicity of arsenite. Arsenite compounds (and related salts, e.g., potassium arsenite) have been used historically as pesticides and therapeutic agents, but their medical use is now obsolete due to severe toxicity[3]. Arsenite is slightly more toxic than arsenate (+5 form), but both pose substantial health risks; they are easily interconverted in biological and environmental systems[4]. No major pharmaceutical brands currently use arsenite as an active drug.

Other names
arsenic(III)arsenic trioxide (when hydrated or in common pharmaceutical form)arsenous acid (when protonated)AsO₂⁻ (main oxyanion form)AsO₃³⁻ (another oxyanion form)arsenic oxyanion (+3 state)
02

Targets

PDH (Pyruvate dehydrogenase complex)

Beyond the preview

Go deeper on arsenite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arsenite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call